Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

22nd Century Group, Inc - Common Stock (NQ:XXII)

1.160 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about 22nd Century Group, Inc - Common Stock

< Previous 1 2
...
16 17 18 19 20 21 22 23 Next >
22nd Century Group To Host Q4 & FY 2021 Earnings Call
22nd Century Group, Inc. (NASDAQ: XXII) announced that it will host a live webcast on Tuesday, March 1, 2022, at 10:00 AM ET to discuss its 2021 fourth quarter and full year results. 
Via Benzinga
Cannabis Stock Gainers And Losers From February 2, 2022
GAINERS: Item 9 Labs (OTC:INLB) shares closed up 7.14% at $1.20 
Via Benzinga
Cannabis Stock Gainers And Losers From January 31, 2022
GAINERS: Greenlane Hldgs (NASDAQ:GNLN) shares closed up 18.20% at $0.76 
Via Benzinga
XXII Stock Alert: Why Is 22nd Century Group Soaring Higher Today?
Agricultural biotech company 22nd Century Group is celebrating an FDA designation. As a result, XXII stock is up 40% today. 
Via InvestorPlace
Cannabis Stock Gainers And Losers From January 27, 2022
GAINERS: MGC Pharmaceuticals (OTC:MGCLF) shares closed up 8.27% at $0.03 
Via Benzinga
Cannabis Stock Gainers And Losers From January 21, 2022
GAINERS: Item 9 Labs (OTC: 
Via Benzinga
Cannabis Stock Gainers And Losers From January 20, 2022
GAINERS: Icanic Brands (OTC: 
Via Benzinga
Cannabis Stock Gainers And Losers From January 19, 2022
GAINERS: Heritage Cannabis Holding (OTC: 
Via Benzinga
Cannabis Stock Gainers And Losers From January 18, 2022
GAINERS: Item 9 Labs (OTC: 
Via Benzinga
Cannabis Stock Gainers And Losers From January 13, 2022
GAINERS: MGC Pharmaceuticals (OTC: 
Via Benzinga
Cannabis Stock Gainers And Losers From January 12, 2022
GAINERS: Cannabix Technologies (OTC: 
Via Benzinga
Cannabis Stock Gainers And Losers From January 5, 2022
GAINERS: Rhinomed (OTC: 
Via Benzinga
Mid-Afternoon Market Update: Dow Surges 275 Points; SciPlay Shares Slide
Toward the end of trading Thursday, the Dow traded up 0.77% to 36,030 while the NASDAQ rose 1% to 15,677. The S&P also rose, gaining 0.81% to 4,734.65. The U.S. has the... 
Via Benzinga
54 Biggest Movers From Thursday
Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of... 
Via Benzinga
Mid-Day Market Update: Nasdaq Rises 100 Points; Quidel Shares Plummet
Midway through trading Thursday, the Dow traded up 0.62% to 35,975.34 while the NASDAQ rose 0.66% to 15,624.94. The S&P also rose, gaining 0.67% to 4,728.06. The U.S. has the... 
Via Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) jumped 37.3% to $2.0182. Pasithea recently said it expanded its footprint with second Ketamine Therapy Clinic in the UK.... 
Via Benzinga
Aurora Cannabis, 22nd Century Group To License Biosynthesis Intellectual Property To Cronos
Canadian marijuana titan Aurora Cannabis Inc. (NASDAQ:ACB) ... 
Via Benzinga
New Kid In Town — Cannabis Daily December 9, 2021
The Best Daily Overview Of The Cannabis Space Valens Co. Commences Trading on NASDAQ under symbol $VLNS Public co... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Movers & Shakers: Leafly, Origin Therapeutics, ECGI Holdings, 22nd Century Group
Leafly Hires Rebecca Warner As VP Of Sales The cannabis information platform Leafly Holdings, Inc. said Wednesday that... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
12 Consumer Staples Stocks Moving In Friday's After-Market Session
Gainers BIMI International (NASDAQ:BIMI 
Via Benzinga
Chart: How Have Cannabis Industry Sectors Performed This Year And What Are Their Valuation Multiples? Do They Make Sense?
Viridian Capital Advisors breaks the cannabis industry down into 12 sub sectors for purposes of tracking capital raises, M&A activity, valuatio... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Week In Cannabis: Canopy's Earnings, JPMorgan's Restrictions, A Slew Of Earnings, Big Policy Moves
Below is a recap of the main news related to the cannabis industry and markets for the week of November 1st, 2021. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
22nd Century Group Reports Revenue Gains In Q3, Seeks To Monetize Its Hemp & Cannabis Plant Lines
Plant-based biotech company 22nd Century Group, Inc. (NASDAQ:X... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Analyst Lowers Price Targets On These Leading Stocks; $TLRY Enters Spirits Market – Cannabis Daily, November 4, 2021
Start The Day With The Best Daily Pre-Market Overview Of The Cannabis Space Cantor Fitzgerald releases notes on several major can... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Benzinga Announces The 8 'Rising Star' Companies Being Featured On Its Next 'All Access' Show
Benzinga is thrilled to announce the guest lineup for our next All Access show, set to air Thursday, October 7 at 9:00 am ET. Thursday's Guest Lineup The theme... 
Via Benzinga
3 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider... 
Via Benzinga
22nd Century Group (Finally) Unveils Its Third Business
The company says the total addressable market across all its businesses is $1.3 trillion. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Cannabidiol Market Size Passed $7 Billion In 2020, Estimated To Grow At Over 35% CAGR Between 2021 And 2027
Via FinancialNewsMedia
Topics Cannabis
Exposures COVID-19 Cannabis
22nd Century Group's Return On Capital Employed Insights
Benzinga Pro data, 22nd Century Group (AMEX:XXII) reported Q2 sales of $8.37 million. Earnings fell to a loss of $6.64 million, resulting in a 28.41% decrease from last quarter.... 
Via Benzinga
48 Biggest Movers From Yesterday
Gainers RenovoRx, Inc. (NASDAQ: RNXT) climbed 107.8% to close at $16.02 on Monday after the company was granted FDA clearance for ‘Catheter, Intravascular Occluding,... 
Via Benzinga
Exposures Product Safety
< Previous 1 2
...
16 17 18 19 20 21 22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.